- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-2i8 vector system (AAV-2i8 expression system, AAV-2i8 packaging plasmid system ) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV-2i8 Vector system is including: 1) AAV-2i8 Rep-Cap plasmid (AAV-2i8-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV-2i8 particle in 293T cell line in high titer using GeneMedi's AAV-2i8 Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV-2i8 vector has been validated in heart, liver, skeletal muscle, lung, kidney, brain, and retina with potential applications in tissue-specific gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Go to AAV
vector system
>>
Manual
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-PK24 | AAV-2i8 Vector System (Amp resistance) 1. AAV-2i8 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3379 | ||
| P-PK24 | AAV-2i8 Vector System (Amp resistance) 1. AAV-2i8 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-PK24 | AAV-2i8 Vector System (Amp resistance) 1. AAV-2i8 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK24 | AAV-2i8 Vector System (Amp resistance) 1. AAV-2i8 Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK24-Kan | AAV-2i8 Vector System (Kan resistance) 1. AAV-2i8 Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC24 | AAV-2i8 Rep-Cap
Plasmid (Amp resistance)
Size：5ug |
Academic | 2062 | ||
| P-RC24 | AAV-2i8 Rep-Cap
Plasmid (Amp resistance)
Size：5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-RC24 | AAV-2i8 Rep-Cap
Plasmid (Amp resistance)
Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC24 | AAV-2i8 Rep-Cap
Plasmid (Amp resistance)
Size：≥10mg |
All | |||
| P-RC24-Kan | AAV-2i8 Rep-Cap
Plasmid(Kan resistance)
Size：≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 | Signal Transduction and Targeted Therapy | 2023/2/3 |
| Small extracellular vesicles deliver osteolytic effectors and mediate cancer‐induced osteolysis in bone metastatic niche | J Extracell Vesicles | 2021/1/25 |
| BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer | Journal of Clinical Investigation | 2022/11/15 |
| The gut microbe Bacteroides fragilis ameliorates renal fibrosis in micec | Nature Communications | 2022/10/14 |
| Camouflaging multifunctional nanoparticles with bacterial outer membrane for augmented chemodynamic/photothermal/starvation/chemo multimodal synergistic therapy of orthotopic glioblastoma | Chemical Engineering Journal | 2023/6/26 |
| [PDF] Role of Argininosuccinate Synthase 1‐Dependent L‐Arginine Biosynthesis in the Protective Effect of Endothelial Sirtuin 3 Against Atherosclerosis | Advanced Science | 2024/1/17 |
| Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways | Acta Pharmaceutica Sinica B | 2022/9/29 |
| Circular RNA circStag1 promotes bone regeneration by interacting with HuR | Bone Research | 2022/3/31 |
| Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1α pathway | JOURNAL OF PINEAL RESEARCH | 2018/3/12 |
| Improved calcium sensor GCaMP-X overcomes the calcium channel perturbations induced by the calmodulin in GCaMP | Nature Communications | 2018/4/12 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
